{
  "ptid_time": "127_S_4197_2015-09-21",
  "img_path": "/data/qiuhui/data/adni/images/127_S_4197/2015-09-21/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 3,958 mm³, 43.2% below the reference mean. With a Z-score of -3.73 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 83.3 years. Gender is Male. Education: 20 years. MMSE: 26.0. MoCA: 21.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.56 SUVR (profound elevated); Amyloid beta: 600.10 pg/mL (mild reduced); Total tau: 207.30 pg/mL (normal ); Phosphorylated tau: 17.78 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume is severely reduced (43.2% below mean, Z-score -3.73), indicating significant neurodegeneration. Despite a relatively preserved MMSE (26), the MoCA (21) suggests mild cognitive impairment, and elevated AV45 (amyloid PET) supports amyloid pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**, likely due to Alzheimer’s pathology (given hippocampal atrophy + amyloid elevation).  \n\n**Confidence:** **High** (clear structural and biomarker evidence, though clinical symptoms are not yet severe enough for dementia).  \n\n*Note: Progression to dementia is highly likely given the degree of hippocampal atrophy and amyloid burden.*",
  "timestamp": "2025-07-26T13:14:27.957150"
}